"The U.S. Food and Drug Administration today approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ("...
Atrovent HFA Patient Information including How Should I Take
In this Article
- What is ipratropium inhalation (Atrovent HFA)?
- What are the possible side effects of ipratropium inhalation (Atrovent HFA)?
- What is the most important information I should know about ipratropium inhalation (Atrovent HFA)?
- What should I discuss with my healthcare provider before using ipratropium inhalation (Atrovent HFA)?
- How should I use ipratropium inhalation (Atrovent HFA)?
- What happens if I miss a dose (Atrovent HFA)?
- What happens if I overdose (Atrovent HFA)?
- What should I avoid while using ipratropium inhalation (Atrovent HFA)?
- What other drugs will affect ipratropium inhalation (Atrovent HFA)?
- Where can I get more information?
What should I discuss with my healthcare provider before using ipratropium inhalation (Atrovent HFA)?
You should not use this medication if you are allergic to ipratropium or atropine.
To make sure ipratropium is safe for you, tell your doctor if you have:
- narrow-angle glaucoma; or
- an enlarged prostate, bladder obstruction, or urination problems.
FDA pregnancy category B. Ipratropium is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether ipratropium passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
Do not give this medicine to a child without medical advice.
How should I use ipratropium inhalation (Atrovent HFA)?
Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.
Ipratropium will not work fast enough to treat an bronchospasm attack. Use only a fast acting inhalation medicine to treat an bronchospasm attack.
Prime the inhaler device before the first use by pumping 2 test sprays into the air, away from your face. Prime the inhaler if it has not been used for longer than 3 days. Clean the inhaler once a week. Follow the cleaning directions that came with your medicine.
The dose indicator on the inhaler will turn from green to red when there are 40 doses left in the device. Get your prescription refilled before you run out of medicine completely. Always use the new device provided with the medication when you get your prescription filled.
Call your doctor right away if it seems like your medications don't work as well, or if your condition gets worse.
While using ipratropium, your lung function may need to be tested often.
Keep the medicine canister away from open flame or high heat, such as in a car on a hot day. The canister may explode if it gets too hot. Do not puncture or burn an empty inhaler canister.
Store the inhaler device with the cover on, at room temperature away from moisture and heat. Throw away the inhaler canister when the dose indicator reaches 0, even if it feels like there is still medicine in it.
Additional Atrovent HFA Information
- Atrovent HFA Drug Interactions Center: ipratropium bromide inhl
- Atrovent HFA Side Effects Center
- Atrovent HFA Overview including Precautions
- Atrovent HFA FDA Approved Prescribing Information including Dosage
Atrovent HFA - User Reviews
Atrovent HFA User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.